ATEV Trademark

Trademark Overview


On Friday, August 2, 2024, a trademark application was filed for ATEV with the United States Patent and Trademark Office. The USPTO has given the ATEV trademark a serial number of 98679748. The federal status of this trademark filing is OPPOSITION PENDING as of Saturday, December 6, 2025. This trademark is owned by Humacyte Global, Inc.. The ATEV trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Bioengineered human connective tissue intended for subsequent implantation; biological implants comprising connective tissue; biological tissue grafts; vascular grafts; bioengineered blood vessels comprising connective tissue intended for subsequent implantation; biological connective tissue implants comprising tissue for use in surgery and regenerative medicine; human tissue substitute comprising connective tissue material derived from biological tissue intended for subsequent implantation.

Product development services, namely, developing biological tissue and bioengineered cells and tissue for medical and clinical use; Research and development of bioengineered tissue; Scientific research in the field of bioengineering and regenerative medicine; Providing information in the field of bioengineering

Providing information in the field of regenerative medicine
atev

General Information


Serial Number98679748
Word MarkATEV
Filing DateFriday, August 2, 2024
Status774 - OPPOSITION PENDING
Status DateSaturday, December 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2025

Trademark Statements


Goods and ServicesBioengineered human connective tissue intended for subsequent implantation; biological implants comprising connective tissue; biological tissue grafts; vascular grafts; bioengineered blood vessels comprising connective tissue intended for subsequent implantation; biological connective tissue implants comprising tissue for use in surgery and regenerative medicine; human tissue substitute comprising connective tissue material derived from biological tissue intended for subsequent implantation.
Goods and ServicesProduct development services, namely, developing biological tissue and bioengineered cells and tissue for medical and clinical use; Research and development of bioengineered tissue; Scientific research in the field of bioengineering and regenerative medicine; Providing information in the field of bioengineering
Goods and ServicesProviding information in the field of regenerative medicine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 2, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 2, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 2, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHumacyte Global, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27713

Party NameHumacyte Global, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27713

Trademark Events


Event DateEvent Description
Friday, August 2, 2024NEW APPLICATION ENTERED
Thursday, January 23, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 10, 2025ASSIGNED TO EXAMINER
Tuesday, February 11, 2025NON-FINAL ACTION WRITTEN
Tuesday, February 11, 2025NON-FINAL ACTION E-MAILED
Tuesday, February 11, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 18, 2025LETTER OF PROTEST EVIDENCE FORWARDED
Wednesday, February 19, 2025LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Thursday, May 8, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, May 8, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, August 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 8, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 1, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 7, 2025PUBLISHED FOR OPPOSITION
Tuesday, October 7, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 5, 2025EXTENSION OF TIME TO OPPOSE RECEIVED
Saturday, December 6, 2025OPPOSITION INSTITUTED NO. 999999
Saturday, December 6, 2025EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED